June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Deep-learning fusion of OCT imaging and traditional risk factors to improve dementia detection in AlzEye
Author Affiliations & Notes
  • Robbert R. R. Struyven
    University College London Centre for Medical Image Computing, London, United Kingdom
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • Dominic Williamson
    University College London Institute of Ophthalmology, London, London, United Kingdom
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • Siegfried Wagner
    University College London Institute of Ophthalmology, London, London, United Kingdom
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • David Romero-Bascones
    Mondragon Unibertsitatea, Mondragon, Pais Vasco, Spain
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • Yukun Zhou
    University College London Centre for Medical Image Computing, London, United Kingdom
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • Timing Liu
    University of Cambridge, Cambridge, Cambridgeshire, United Kingdom
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • Yue Wu
    University of Washington Department of Ophthalmology, Seattle, Washington, United States
  • Konstantinos Balaskas
    University College London Institute of Ophthalmology, London, London, United Kingdom
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • Mario Cortina Borja
    University College London Great Ormond Street Institute of Child Health Library, London, London, United Kingdom
  • Jugnoo Rahi
    University College London Great Ormond Street Institute of Child Health Library, London, London, United Kingdom
    Great Ormond Street Hospital for Children NHS Foundation Trust, London, London, United Kingdom
  • Axel Petzold
    University College London Institute of Ophthalmology, London, London, United Kingdom
    UCL Queen Square Institute of Neurology, London, London, United Kingdom
  • Aaron Y Lee
    University of Washington Department of Ophthalmology, Seattle, Washington, United States
    Roger and Angie Karalis Johnson Retina Center, Seattle, Washington, United States
  • Cecilia S. Lee
    University of Washington Department of Ophthalmology, Seattle, Washington, United States
    Roger and Angie Karalis Johnson Retina Center, Seattle, Washington, United States
  • Alastair K Denniston
    University Hospitals Birmingham NHS Foundation Trust, Birmingham, Birmingham, United Kingdom
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • Daniel Alexander
    University College London Centre for Medical Image Computing, London, United Kingdom
  • Pearse Keane
    University College London Institute of Ophthalmology, London, London, United Kingdom
    NIHR Moorfields Biomedical Research Centre, London, Greater London, United Kingdom
  • Footnotes
    Commercial Relationships   Robbert R. Struyven None; Dominic Williamson None; Siegfried Wagner None; David Romero-Bascones None; Yukun Zhou None; Timing Liu None; Yue Wu None; Konstantinos Balaskas None; Mario Cortina Borja None; Jugnoo Rahi None; Axel Petzold Novartis, Code C (Consultant/Contractor), Heidelberg Engineering, Roche, Code R (Recipient); Aaron Lee Santen, Carl Zeiss Meditec, Microsoft, NVIDIA, and Novartis, and personal fees from Genentech, Verana Health, Gyroscope, Topcon, and Johnson and Johnson, Code F (Financial Support); Cecilia Lee Alzheimer's disease Drug Discovery Foundation (ADDF), Code F (Financial Support); Alastair Denniston None; Daniel Alexander None; Pearse Keane Apellis, Code C (Consultant/Contractor), Allergan, Topcon, Heidelberg Engineering, Novartis, Roche, Bayer, Code F (Financial Support), Big Picture Medical, Code I (Personal Financial Interest)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1282. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Robbert R. R. Struyven, Dominic Williamson, Siegfried Wagner, David Romero-Bascones, Yukun Zhou, Timing Liu, Yue Wu, Konstantinos Balaskas, Mario Cortina Borja, Jugnoo Rahi, Axel Petzold, Aaron Y Lee, Cecilia S. Lee, Alastair K Denniston, Daniel Alexander, Pearse Keane; Deep-learning fusion of OCT imaging and traditional risk factors to improve dementia detection in AlzEye. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1282.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : For dementia screening, the benefit of incorporating retinal information, in addition to traditional non-retinal risk factors (TRFs), has not yet been fully established. Here, we compare the performance of four models in screening for prevalent all-cause dementia using I. non-retinal TRFs, II. a combination of retinal layer thickness measurements and TRFs, III. a deep learning algorithm trained on OCT images, and IV. a multi-modal fusion model combining OCTs and TRFs.

Methods : The AlzEye study includes 353,157 patients who visited Moorfields Eye Hospital (MEH) from 2008 to 2018. We developed a multi-modal fusion model that combined both TRFs and retinal features. Traditional risk factors composed of I. TRFs - demographic (age, sex, ethnicity, deprivation index) and clinical features (hypertension, diabetes). Retinal features consisted of both II. OCT ETDRS layer thicknesses, and IV. automatically-learned features extracted by a convolutional neural network (CNN). Models were trained on data from 26,603 patients visiting four MEH hospitals, and validated on two test datasets; 2,946 independent patients visiting the same four hospitals (test set 1), and 2,966 independent patients visiting three distinct hospitals (test set 2).

Results : In predicting dementia, the Area Under the Receiver-Operator Curve (AUROC) of the non-retinal TRFs was 0.808, and 0.776 in test sets 1 and 2. The AUROC of the deep learning OCT image model was 0.777, and 0.710 respectively. The addition of the OCT layer thicknesses to the TRFs resulted in an AUROC of 0.812 and 0.784 (best) respectively. The addition of deep learning features to the TRFs resulted in an AUROC of 0.833 (best) and 0.773 in test sets 1 and 2.

Conclusions : We show in two retrospective independent UK validation sets that retinal data, in addition to traditional non-retinal risk factors, can boost performance in detecting all-cause dementia. In our validation sets both the interpretable retinal features defined by physicians, as well as the black-box retinal features extracted by deep learning, improved performance. This highlights the potential benefit of using retinal images for dementia screening in a community setting.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Fig 1. Linkage and dementia dataset curation approach for AlzEye.
Fig 2. Models.

Fig 1. Linkage and dementia dataset curation approach for AlzEye.
Fig 2. Models.

 

Table 1. AUROC results with 95% confidence intervals for each model (1000 sample bootstrapping).

Fig 3. Violin plots displaying AUROC distributions.

Table 1. AUROC results with 95% confidence intervals for each model (1000 sample bootstrapping).

Fig 3. Violin plots displaying AUROC distributions.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×